549 related articles for article (PubMed ID: 20048167)
1. Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers.
Adam AP; Sharenko AL; Pumiglia K; Vincent PA
J Biol Chem; 2010 Mar; 285(10):7045-55. PubMed ID: 20048167
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of endothelial cell permeability by high and low doses of oxidized 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphocholine.
Starosta V; Wu T; Zimman A; Pham D; Tian X; Oskolkova O; Bochkov V; Berliner JA; Birukova AA; Birukov KG
Am J Respir Cell Mol Biol; 2012 Mar; 46(3):331-41. PubMed ID: 21997484
[TBL] [Abstract][Full Text] [Related]
3. A novel role of vascular endothelial cadherin in modulating c-Src activation and downstream signaling of vascular endothelial growth factor.
Ha CH; Bennett AM; Jin ZG
J Biol Chem; 2008 Mar; 283(11):7261-70. PubMed ID: 18180305
[TBL] [Abstract][Full Text] [Related]
4. TLR4 signaling is coupled to SRC family kinase activation, tyrosine phosphorylation of zonula adherens proteins, and opening of the paracellular pathway in human lung microvascular endothelia.
Gong P; Angelini DJ; Yang S; Xia G; Cross AS; Mann D; Bannerman DD; Vogel SN; Goldblum SE
J Biol Chem; 2008 May; 283(19):13437-49. PubMed ID: 18326860
[TBL] [Abstract][Full Text] [Related]
5. ICAM-1-mediated, Src- and Pyk2-dependent vascular endothelial cadherin tyrosine phosphorylation is required for leukocyte transendothelial migration.
Allingham MJ; van Buul JD; Burridge K
J Immunol; 2007 Sep; 179(6):4053-64. PubMed ID: 17785844
[TBL] [Abstract][Full Text] [Related]
6. eNOS-derived nitric oxide regulates endothelial barrier function through VE-cadherin and Rho GTPases.
Di Lorenzo A; Lin MI; Murata T; Landskroner-Eiger S; Schleicher M; Kothiya M; Iwakiri Y; Yu J; Huang PL; Sessa WC
J Cell Sci; 2013 Dec; 126(Pt 24):5541-52. PubMed ID: 24046447
[TBL] [Abstract][Full Text] [Related]
7. Proline-rich tyrosine kinase 2 (Pyk2) mediates vascular endothelial-cadherin-based cell-cell adhesion by regulating beta-catenin tyrosine phosphorylation.
van Buul JD; Anthony EC; Fernandez-Borja M; Burridge K; Hordijk PL
J Biol Chem; 2005 Jun; 280(22):21129-36. PubMed ID: 15778498
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of VE-cadherin controls endothelial phenotypes via p120-catenin coupling and Rac1 activation.
Hatanaka K; Simons M; Murakami M
Am J Physiol Heart Circ Physiol; 2011 Jan; 300(1):H162-72. PubMed ID: 21037229
[TBL] [Abstract][Full Text] [Related]
9. Pyk2 phosphorylation of VE-PTP downstream of STIM1-induced Ca
Soni D; Regmi SC; Wang DM; DebRoy A; Zhao YY; Vogel SM; Malik AB; Tiruppathi C
Am J Physiol Lung Cell Mol Physiol; 2017 Jun; 312(6):L1003-L1017. PubMed ID: 28385807
[TBL] [Abstract][Full Text] [Related]
10. VEGF-induced vascular permeability is mediated by FAK.
Chen XL; Nam JO; Jean C; Lawson C; Walsh CT; Goka E; Lim ST; Tomar A; Tancioni I; Uryu S; Guan JL; Acevedo LM; Weis SM; Cheresh DA; Schlaepfer DD
Dev Cell; 2012 Jan; 22(1):146-57. PubMed ID: 22264731
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine phosphorylation of vascular endothelial cadherin and the regulation of microvascular permeability.
Nwariaku FE; Liu Z; Zhu X; Turnage RH; Sarosi GA; Terada LS
Surgery; 2002 Aug; 132(2):180-5. PubMed ID: 12219009
[TBL] [Abstract][Full Text] [Related]
12. eNOS-induced vascular barrier disruption in retinopathy by c-Src activation and tyrosine phosphorylation of VE-cadherin.
Ninchoji T; Love DT; Smith RO; Hedlund M; Vestweber D; Sessa WC; Claesson-Welsh L
Elife; 2021 Apr; 10():. PubMed ID: 33908348
[TBL] [Abstract][Full Text] [Related]
13. Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site.
Wallez Y; Cand F; Cruzalegui F; Wernstedt C; Souchelnytskyi S; Vilgrain I; Huber P
Oncogene; 2007 Feb; 26(7):1067-77. PubMed ID: 16909109
[TBL] [Abstract][Full Text] [Related]
14. The role of adherens junctions and VE-cadherin in the control of vascular permeability.
Dejana E; Orsenigo F; Lampugnani MG
J Cell Sci; 2008 Jul; 121(Pt 13):2115-22. PubMed ID: 18565824
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation.
Lin MT; Yen ML; Lin CY; Kuo ML
Mol Pharmacol; 2003 Nov; 64(5):1029-36. PubMed ID: 14573751
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor signaling potentiates VE-cadherin stability at adherens junctions by regulating SHP2.
Hatanaka K; Lanahan AA; Murakami M; Simons M
PLoS One; 2012; 7(5):e37600. PubMed ID: 22629427
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway.
Liu D; Xu H; Zhang C; Xie H; Yang Q; Li W; Tian H; Lu L; Xu JY; Xu G; Liu K; Sun X; Xu GT; Zhang J
Life Sci; 2020 Oct; 259():118273. PubMed ID: 32800831
[TBL] [Abstract][Full Text] [Related]
18. The integrin antagonist cilengitide activates alphaVbeta3, disrupts VE-cadherin localization at cell junctions and enhances permeability in endothelial cells.
Alghisi GC; Ponsonnet L; Rüegg C
PLoS One; 2009; 4(2):e4449. PubMed ID: 19212436
[TBL] [Abstract][Full Text] [Related]
19. The tyrosine phosphatase SHP2 regulates recovery of endothelial adherens junctions through control of β-catenin phosphorylation.
Timmerman I; Hoogenboezem M; Bennett AM; Geerts D; Hordijk PL; van Buul JD
Mol Biol Cell; 2012 Nov; 23(21):4212-25. PubMed ID: 22956765
[TBL] [Abstract][Full Text] [Related]
20. Regulation of endothelial barrier function by p120-catenin∙VE-cadherin interaction.
Garrett JP; Lowery AM; Adam AP; Kowalczyk AP; Vincent PA
Mol Biol Cell; 2017 Jan; 28(1):85-97. PubMed ID: 27852896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
